A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia.

导出 OA

翻译打印收藏纠错

作者： José Luis,Marín-Rubio ^[1] ; Rachel E,Peltier-Heap ^[1] ; Maria Emilia,Dueñas ^[1] ; Tiaan,Heunis ^[1] ; Abeer,Dannoura ^[2] ; Joseph,Inns ^[1] ; Jonathan,Scott ^[1] ; A John,Simpson ^[3] ; Helen J,Blair ^[3] ; Olaf,Heidenreich ^[4] ; James M,Allan ^[5] ; Jessica E,Watt ^[5] ; Mathew P,Martin ^[5] ; Barbara,Saxty ^[6] ; Matthias,Trost ^[6]

作者单位： Laboratory for Biological Mass Spectrometry, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne NE2 4HH, UK. ^[1] Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. ^[2] Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE2 4HH, UK. ^[3] Respiratory Medicine Unit, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK. ^[4] Translational and Clinical Research Institute, Newcastle University, Herschel Building, Level 6, Brewery Lane, Newcastle upon Tyne NE1 7RU, UK. ^[5] Newcastle Cancer Centre, Northern Institute for Cancer Research, Medical School, Newcastle University, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. ^[6] LifeArc, SBC Open Innovation Campus, Stevenage SG1 2FX, UK. ^[7]